Parker Waichman LLP

Heparin Problems Not Our Fault, Chinese Official Says

A counterfeit ingredient found in batches of recalled heparin is not to blame for the deaths and reactions seen in U.S. patients treated with the drug, a Chinese government official claimed today.  Jin Shaohong, deputy director-general of the China National Institute for the Control of Pharmaceutical and Biological Products, insisted that problems with heparin sold […]

A counterfeit ingredient found in batches of recalled <"https://www.yourlawyer.com/topics/overview/heparin">heparin is not to blame for the deaths and reactions seen in U.S. patients treated with the drug, a Chinese government official claimed today.  Jin Shaohong, deputy director-general of the China National Institute for the Control of Pharmaceutical and Biological Products, insisted that problems with heparin sold by Baxter International originated in the U.S. and said regulators from China will soon arrive here to inspect the New Jersey plant that finishes processing Baxter heparin.

Baxter International recalled nearly all its heparin injections in the US after some patients experienced extreme – and in some cases fatal – allergic reactions, including difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that was life threatening after being administered the products. There have been similar recalls by other manufacturers of Chinese-sourced heparin in Denmark, Italy, France Germany and Japan. In the US, heparin has been associated with the deaths of more than 100 people since early 2007, according to the Food & Drug Administration (FDA). Of those, the vast majority – 62 to be exact – were associated with contaminated batches of heparin.

In March, the FDA confirmed that it had found oversulfated chondroitin sulfate in samples of the active ingredient used in Baxter heparin. The FDA said the chondroitin sulfate was molecularly changed to mimic heparin’s blood-clotting properties. That ingredient was supplied to Baxter by Changzhou SPL, a Chinese plant partially owned by Wisconsin-based Scientific Protein Laboratories LLC. It costs a fraction of the ingredient usually used in heparin, and producers may have used it in an attempt to cut costs. Last week, FDA Commissioner Andrew von Eschenbach said that while the FDA has no specific evidence that the chondroitin sulfate contamination was intentional, “the concern is that it had to be by design.”

However, the Chinese are disputing that the chondroitin sulfate has anything to do with the heparin injuries seen in the US.  Shaohong said that Chinese investigators tested batches of heparin used by patients who reported health problems, and only some contained chondroitin sulfate. “The oversulfated chondroitin can therefore not be the suspected root cause of heparin ADE (adverse events),” he told reporters at a news conference this morning.

Shaohong also said Chinese officials are focusing on the whole product and planned to visit Baxter’s plant in New Jersey later on Monday. “They will cooperate with us, no problem,” he told reporters. Shaohong speculated that other contaminants, problems with the device used to inject the heparin, or health factors with the patients who used the drug could also be causing the reactions.

Despite Shaohong’s insistence that Chinese manufacturing is blameless in the heparin debacle, counterfeit ingredients have caused problems with Chinese imports in the past.  The news of heparin contamination came almost one year after some pets in the US died as the result of a pet food ingredient shipped from China that contained toxic levels of melamine, which was added to make it appear higher in protein. In Panama around the same time, 120 people died because an unlicensed Chinese chemical plant sold a cheap counterfeit ingredient, diethylene glycol, that was mixed into cold medicine imported to that country. Diethylene glycol contamination also resulted in a recall of Chinese-made toothpaste in the US over the summer.

China has also made efforts to crack down on heparin producers since it became apparent that something had gone wrong with the drug.  According to a report in The Wall Street Journal, the Chinese State Food and Drug Administration issued an order in a notice seen on its Web site that requires heparin producers to obtain the raw chemicals used to make the drug from registered suppliers. Raw heparin suppliers, meanwhile, are required to improve their management and tests on their products, it said. This was a reversal of the Chinese government’s earlier position, as the agency had earlier insisted that ensuring the quality of exported chemicals like heparin was the responsibility of importers and importing countries.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
HELLO IM VERY PLEASED WITH HIGH QUALITY OF SERVICE THAT MS ASHLEY LOPILATO PROVIDED TO ME DURING MY HARD STRUGGLE WITH THE MEDICAL RECORDS DEPARTMENT AND MY COMPANY ABM EVEN THOUGH I WAS READY TO GIVE UP ASHLEY CONTINUED TO CONSOLE ME AND UP MY SPRIT WHAT CAN I NOT SAY ABOUT ASHLEY SHE IS A GREAT ASSET TO THIS FIRM I TRULY FEEL EVEN THOUGH I NEVER MET HER ASHLEY MADE ME FEEL LIKE I KNOWN HER FOR YEARS WE TALKED LAUGHED AND TRULY SPOKE OF A LEVEL OF BEYOND CLIENT ATTORNEY RELATIONSHIP PLEASE IF NO ONE KNOWS ABOUT ASHELY MAKE SURE SOMEONE READS THIS LETTLE NO BETTER YET THIS DEVOTED APPRECIATION COMPLIMENT ON HER BEAUTIFUL WILL TO MAKE ME FEEL SPECIAL THANK YOU PARKER WAICHMAN FOR EMPLOYING SUCH A VERY GOOD PERSON THANKS AGAIN ASHLEY YOU NEVER SEEN BEFORE FRIEND DWAYNE BASDEN
Dwayne Basden
3 years ago
5 Star Reviews 150
The law firm worked with me on a victim compensation fund. Christina Morace was the paralegal and through the long process she called me to keep me up to date. She let me know what paperwork was coming and what it meant. She also called to explain the time table for each part. I did not have to wonder about what was happening. I really appreciate her work and the others at Parker Waichman.
Shauna N
2 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness Benita Rollis was very helpful and kept me informed on every step of the process of my case.
Jose Crespo
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038